Skip to Content
From the president

The MIT scientists behind the Moderna vaccine

Decades of research and bold entrepreneurship paved the way for the vaccine’s “overnight” success.

February 23, 2021
MIT President L.Rafael Reif
MIT President L.Rafael Reif
Simon Simard

By the time you read this, I hope the breakthrough efforts of brilliant scientists will have stemmed the tide of covid-19 and lessened its devastating effects. But the past year has defied prediction, and as I write this letter in the early days of 2021, I hesitate to guess what the spring will hold. We can certainly all take pride, however, in the fact that MIT people have been a vital force in fighting this deadly pandemic—and no example stands out more than the pioneering work to bring forth an anti-covid vaccine. 

Like the other firms that developed successful vaccines, Moderna has quickly become a household name, and to the general public its mRNA vaccine appeared to be an overnight success. But as MIT readers will naturally understand, it was the product of decades of rigorous research, combined with bold entrepreneurship. And MIT people, places, and ideas were central to its development. 

The origins of both the Moderna and Pfizer vaccines can be found in the early days of biotech—before Kendall Square was known as “the most innovative square mile on the planet.” In the 1970s, at MIT’s Center for Cancer Research, Phil Sharp discovered RNA splicing and revealed the potential of mRNA. Now an Institute Professor and Nobel laureate, Phil recalls, “I’ve been involved in biotech almost since the word was invented. We had a new science, and we knew it would impact the world.”

In the 1980s, Moderna cofounder Bob Langer, PhD ’74, was pioneering new ways to deliver medicines, including RNA—work that ultimately contributed to the development of the new vaccine. But the early years included lots of discouragement. As Bob, now an Institute Professor as well, remembers it, “Everybody told us it was impossible, and my first nine grants were rejected … I found over 200 ways to get it to not work. But then eventually I did find a way to get it to work.” 

Noubar Afeyan, PhD ’87, another cofounder of Moderna and its chairman, got into biotech after earning his doctorate in biochemical engineering. Since then, he has helped found dozens of startups, operating on the belief that scientists should start not by looking at problems they want to solve, but by coming up with “unreasonable” solutions—and figuring out how to realize them.

Making an impact. Refusing to give up despite daunting setbacks. Envisioning impossible solutions. Sound familiar? The contributions of these three notable members of our community reflect the essential mission and character of MIT.

As the pandemic persists, we continue to advance that mission under tremendous strain, painfully aware that we cannot know what lies around the corner. But we can find great inspiration in the vital and varied contributions from the people of MIT to the fight against covid-19.

Keep Reading

Most Popular

still from Embodied Intelligence video
still from Embodied Intelligence video

These weird virtual creatures evolve their bodies to solve problems

They show how intelligence and body plans are closely linked—and could unlock AI for robots.

pig kidney transplant surgery
pig kidney transplant surgery

Surgeons have successfully tested a pig’s kidney in a human patient

The test, in a brain-dead patient, was very short but represents a milestone in the long quest to use animal organs in human transplants.

panpsychism concept
panpsychism concept

Is everything in the world a little bit conscious?

The idea that consciousness is widespread is attractive to many for intellectual and, perhaps, also emotional
reasons. But can it be tested? Surprisingly, perhaps it can.

We reviewed three at-home covid tests. The results were mixed.

Over-the-counter coronavirus tests are finally available in the US. Some are more accurate and easier to use than others.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at with a list of newsletters you’d like to receive.